Balyasny Asset Management
ABMD

Balyasny Asset Management’s Abiomed Inc ABMD Stock Holding History

Balyasny Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,801
Closed -$12.5M – 3430
2022
Q3 		$12.5M Buy
+50,801
New +$13.7M 0.04% 589
2022
Q2 		– Sell
-40,867
Closed -$13.5M – 3344
2022
Q1 		$13.5M Sell
40,867
-46,808
-53% -$14.4M 0.04% 580
2021
Q4 		$31.5M Buy
+87,675
New +$29.6M 0.11% 250
2021
Q2 		– Sell
-77,354
Closed -$23.7M – 2544
2021
Q1 		$24.7M Buy
+77,354
New +$24.8M 0.12% 222
2019
Q3 		– Sell
-6,974
Closed -$1.51M – 1715
2019
Q2 		$1.82M Buy
6,974
+5,200
+293% +$1.38M 0.01% 902
2019
Q1 		$507K Buy
1,774
+969
+120% +$322K ﹤0.01% 1203
2018
Q4 		$262K Buy
+805
New +$280K ﹤0.01% 1254
2018
Q3 		– Sell
-2,387
Closed -$976K – 2151
2018
Q2 		$976K Buy
+2,387
New +$865K ﹤0.01% 1144
2018
Q1 		– Sell
-23,812
Closed -$4.46M – 2428
2017
Q4 		$4.46M Buy
+23,812
New +$4.45M 0.01% 901
2017
Q3 		– Sell
-4,238
Closed -$607K – 2153
2017
Q2 		$607K Buy
+4,238
New +$570K ﹤0.01% 1207
2017
Q1 		– Sell
-29,784
Closed -$3.36M – 1842
2016
Q4 		$3.36M Buy
+29,784
New +$3.45M 0.02% 792

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's ABMD Position: Q4 2022 in Review

Balyasny Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 50,801 shares — an estimated $12.5M sold.

Balyasny Asset Management first reported a position in ABMD in Q4 2016 and held it in 11 quarters. The position peaked at $31.5M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Balyasny Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 50,801 Abiomed Inc shares in Q4 2022, an estimated $12.5M.
  • Balyasny Asset Management first reported a position in Abiomed Inc in Q4 2016 and held it in 11 quarters.
  • Balyasny Asset Management's Abiomed Inc position peaked at $31.5M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.